David A. Spellman

David A. Spellman

Former Senior Vice President, Chief Financial Officer and TreasureratAkebia Therapeutics· In proxies 2021–2023

Pay in FY2023-41% from the year before · Akebia Therapeutics stock +114.9% the same year

David A. Spellman was paid $942.6K in FY2023 (Dec), down 41%. Akebia Therapeutics stock rose 114.9% that year.

Pay$100 in the stock at the end of FY20 → $44
Pay is from the Summary Compensation Table of each Akebia Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Akebia TherapeuticsPublic company · 5 yr
    • Former Senior Vice President, Chief Financial Officer and Treasurer2021 – Present · 5 yrStock in role -74%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?